Cargando…

Teledermatology: A useful tool also after COVID‐19 era?

Detalles Bibliográficos
Autores principales:	Megna, Matteo, Camela, Elisa, Villani, Alessia, Tajani, Andrea, Fabbrocini, Gabriella, Potestio, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Covid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115067/ https://www.ncbi.nlm.nih.gov/pubmed/35332660 http://dx.doi.org/10.1111/jocd.14938

Ejemplares similares

Letter to the editor regarding the article “Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID‐19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.”
por: Potestio, Luca, et al.
Publicado: (2022)

Long‐term results of teledermatology for acne patients during COVID‐19 pandemic
por: Villani, Alessia, et al.
Publicado: (2022)

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
por: Marasca, Claudio, et al.
Publicado: (2022)

Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
por: Martora, Fabrizio, et al.
Publicado: (2023)

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Letter to the editor regarding article “Yalici‐Armagan B, Tabak GH, Dogan‐Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID‐19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1–5”
por: Potestio, Luca, et al.
Publicado: (2021)

Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
por: Megna, Matteo, et al.
Publicado: (2022)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study
por: Megna, Matteo, et al.
Publicado: (2022)

Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting
por: Megna, Matteo, et al.
Publicado: (2022)

Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire
por: Camela, Elisa, et al.
Publicado: (2023)

Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
por: Megna, Matteo, et al.
Publicado: (2022)

Towards Personalized Medicine in Psoriasis: Current Progress
por: Camela, Elisa, et al.
Publicado: (2022)

A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
por: Megna, Matteo, et al.
Publicado: (2022)

Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation
por: Ocampo‐Garza, Sonia Sofia, et al.
Publicado: (2022)

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
por: Megna, Matteo, et al.
Publicado: (2023)

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
por: Megna, Matteo, et al.
Publicado: (2022)

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511”
por: Potestio, Luca, et al.
Publicado: (2022)

COVID‐19 and cutaneous manifestations: A review of the published literature
por: Martora, Fabrizio, et al.
Publicado: (2022)

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
por: Potestio, Luca, et al.
Publicado: (2023)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
por: Martora, Fabrizio, et al.
Publicado: (2023)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study
por: Megna, Matteo, et al.
Publicado: (2022)

New‐onset lichen planus arising after COVID‐19 vaccination
por: Zagaria, Orlando, et al.
Publicado: (2022)

COVID‐19 vaccination and inflammatory skin diseases
por: Martora, Fabrizio, et al.
Publicado: (2022)

A Case of Adult-onset Facial Cutaneous Mastocytoma: Clinical and Dermoscopic Findings
por: Megna, Matteo, et al.
Publicado: (2022)

New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2022)

Repigmentation of White Forelock in a Familial Case of Piebaldism Reported via Teledermatology in the COVID-19 Era
por: Gaudiello, Francesca, et al.
Publicado: (2021)

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
por: Potestio, Luca, et al.
Publicado: (2023)

Rise of teledermatology in the COVID-19 era: A pan-world perspective
por: Naik, Piyu Parth
Publicado: (2022)

A case of pediatric psoriasis successfully and rapidly treated with ixekizumab
por: Megna, Matteo, et al.
Publicado: (2021)

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge
por: Potestio, Luca, et al.
Publicado: (2023)

Herpes Zoster and COVID-19 Vaccination: A Narrative Review
por: Potestio, Luca, et al.
Publicado: (2023)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas
por: Villani, Alessia, et al.
Publicado: (2022)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
por: Potestio, Luca, et al.
Publicado: (2023)

Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
por: Villani, Alessia, et al.
Publicado: (2022)

Teledermatology Adaptations in the COVID-19 Era
por: Edwards, Harrison A., et al.
Publicado: (2021)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_usk1t31r0hpo9i9v9uksrpuvgt